Training engineers to improve cardiovascular medicine
UCLA and Caltech integrated Cardiovascular Medicine for Bioengineers (iCMB)
This program is designed to help scientists and engineers learn how to use new technology and techniques to improve heart health, especially for those who may not have had the same opportunities in the past, by providing hands-on training and support from top companies in the medical field.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10904840 on NIH RePORTER |
What this research studies
This program aims to train biophysical scientists and engineers in the field of cardiovascular medicine by integrating advanced engineering techniques with clinical practices. It focuses on developing skills in flexible electronics for sensing and imaging, along with machine learning applications to tackle cardiometabolic disorders. The curriculum is structured over two years and emphasizes recruiting under-represented individuals into leadership roles in both academia and industry. Participants will engage in hands-on training and mentorship through partnerships with leading companies in the medical field.
Who could benefit from this research
Good fit: Ideal candidates for this research are post-doctoral engineers or biophysical scientists interested in cardiovascular medicine and willing to engage in advanced training.
Not a fit: Patients who are not involved in engineering or biophysical sciences may not directly benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative technologies and approaches that significantly improve the diagnosis and treatment of cardiovascular diseases.
How similar studies have performed: Previous collaborations between UCLA and Caltech have shown success in training programs that integrate engineering with medical sciences.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Hsiai, Tzung K — University of California Los Angeles
- Study coordinator: Hsiai, Tzung K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.